Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
39 /100
MEDIUM RISK
Score updated Oct 13, 2026

LUNG — Pulmonx Corporation Dilution Risk Tracker

Track LUNG dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track LUNG — Get alerts when the score changes →

As of October 13, 2026, Pulmonx Corporation (LUNG) has a DilutionWatch DilutionScore of 39/100, rated MEDIUM dilution risk. Pulmonx Corporation has a market capitalization of $77.31M, 42.95M shares outstanding, 114 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
40
📊 Float Risk
10
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

⛅
Watch
Minor dilution signals detected
model est. 15%
🔄 Reverse Split model est. 30%
• 50-day avg $1.36 approaching $1 threshold
🔔 Track LUNG — Get forecast alerts →

Market Data

Market Cap$77.31M
Shares Outstanding42.95M
Float37.27M
Cash$55.84M
Debt$40.73M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore39/100DilutionWatch score record
Shares Outstanding42.95MVerified float table or market cache
Public Float37.27MVerified float table or market cache
Market Cap$77.31MMarket data cache
Cash Runway14.0 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 2.

Recent SEC source mix: XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 26.9% shares (2026Q1 vs prior)
114 institutional holders · 43.01M shares
#1 MORGAN STANLEY 11.77M shares
#2 PRIMECAP MANAGEMENT CO/CA/ 4.72M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 3.27M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest802.7K
Days to Cover3.2
% of Float2.1%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-08-04
xbrl XBRL CONVERTIBLE 2022-03-01
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual LUNG Dilution Snapshot

Pulmonx Corporation (LUNG) has a DilutionScore of 39/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

LUNG's DilutionScore is currently 39/100 (Medium risk), with 4 score changes tracked over 89 days. The score improved from 35/100 (Medium risk).

Period Score Risk Level Duration
Oct 01 – Oct 13, 202639/100MEDIUM13 days
Sep 24 – Sep 30, 202635/100MEDIUM7 days
Aug 22 – Sep 23, 202640/100MEDIUM33 days
Aug 14 – Aug 21, 202644/100MEDIUM7 days
Jul 16 – Aug 13, 202640/100MEDIUM29 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

LUNG shares outstanding have increased 2.4% from 41.25M (Mar 2026) to 42.24M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 17, 202642.24M37.27M▼ 0.33%
May 06, 202642.24M37.39M▲ 0.81%
May 03, 202642.24M37.09M▼ 0.80%
Mar 19, 202642.24M37.39M▼ 0.99%
Mar 13, 202641.25M37.76M▼ 4.61%
Mar 05, 202641.25M39.59M▲ 0.38%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track LUNG Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment LUNG files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking LUNG — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for LUNG
LUNG FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.